The delivery of another MEK inhibitor, PD98059, in polylactic acid glycolic acid (PLGA) nanoparticles could improve the efficacy of cisplatin delivered via intraperitoneal (i.p.)injection in murine melanoma tumors [11]. Here, MAP2K7 is linked to melanoma.